Animal Drug Compounding Market Research Covering Growth Analysis And Industry Trends with Forecast 2031

The animal drug compounding market provides a wide array of compounded medications, including oral suspensions, flavored chews, transdermal gels, injectable solutions, and topical formulations, tailored to the specific needs and preferences of veterinary patients. Compounded medications may include commercially available active pharmaceutical ingredients (APIs) as well as custom formulations prepared according to veterinary prescription orders, often to address issues such as dose titration, palatability enhancement, or allergen avoidance.

Animal Drug Compounding market is estimated to attain a valuation of US$ 2.4 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 7.4% during the forecast period, 2022-2031

Get a Sample Copy of the Animal Drug Compounding Market Research Report –

The significant players operating in the global Animal Drug Compounding market are- Wedgewood Pharmacy, Triangle Compounding Pharmacy, Davis Islands Pharmacy, Custom Med Compounding Pharmacy, Central Compounding Center South, Wellness Pharmacy of Cary, Caringbah Compounding Pharmacy, Millers Pharmacy, Smith’s Pharmacy, Specialist Compounding Pharmacy Pte Ltd., and Tache Pharmacy

Market Drivers and Dynamics:

  1. Demand for Personalized Veterinary Care: Pet owners and livestock producers increasingly seek personalized healthcare solutions for their animals, driving demand for compounded medications that accommodate individual patient characteristics, species-specific requirements, and treatment preferences.
  2. Shortages of Commercially Available Drugs: Discontinuation, supply chain disruptions, and regulatory challenges may lead to shortages of commercially available veterinary medications, prompting veterinarians to rely on compounded alternatives to ensure continuity of care for their patients.
  3. Treatment of Unique Patient Populations: Exotic animals, avian species, and zoo animals often present unique challenges in medication administration, dosing, and compliance, necessitating compounded formulations tailored to the anatomical, physiological, and behavioral characteristics of these species.
  4. Regulatory Framework and Compliance Standards: Regulatory oversight, quality assurance requirements, and compliance standards play a critical role in shaping the animal drug compounding market, ensuring patient safety, product efficacy, and adherence to good compounding practices.

Regulatory Considerations:

  1. United States: In the United States, animal drug compounding is regulated by the Food and Drug Administration (FDA), which oversees both traditional compounding pharmacies operating under state pharmacy laws and outsourcing facilities registered under the Drug Quality and Security Act (DQSA). Compliance with Current Good Manufacturing Practices (cGMP) is required for outsourcing facilities to ensure product quality and safety.
  2. European Union: Veterinary compounding regulations vary across European Union (EU) member states, with some countries allowing limited compounding by veterinarians for individual patients under specific circumstances, while others have stricter restrictions or prohibitions on compounding practices.

Market Segmentation –

  • Product
    • Anti-infectives
      • Metranidazole
      • Ketaconazole
      • Others
    • Anti-inflammatory
      • Prednisolone
      • Tramadol
      • Others
    • CNS Agents
      • Potassium Bromide
      • Gabapentin
      • Other CNS Agents
    • GI Drugs
      • Apomorphine
      • Ursodiol
      • Cisapride
      • Other GI Drugs
    • Others
      • Methimazole
      • Others
  • Animal Type
    • Companion Animal
      • Dogs
      • Cats
      • Others
    • Livestock
  • Dosage Form
    • Capsules
    • Solutions
    • Powders
    • Suspension
    • Others
  • Route of Administration
    • Oral
    • Injectable
    • Topical
    • Rectal
    • Ocular

This Report lets you identify the opportunities in Animal Drug Compounding Market by means of a region:

  • North America (the United States, Canada, and Mexico)
  • Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
  • South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Transparency Market Research Inc.


1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Si prega di attivare i Javascript! / Please turn on Javascript!

Javaskripta ko calu karem! / Bitte schalten Sie Javascript!

S'il vous plaît activer Javascript! / Por favor, active Javascript!

Qing dakai JavaScript! / Qing dakai JavaScript!

Пожалуйста включите JavaScript! / Silakan aktifkan Javascript!